Ngā hua rapu - Christopher J. Lees

  • E whakaatu ana i te 1 - 10 hua o te 10
Whakamahine hua
  1. 1
    The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality

    The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality mā Patricia A. Taylor, Christopher J. Lees, Bruce R. Blazar

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions

    Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions mā Patricia A. Taylor, Christopher J. Lees, Herman Waldmann, Randolph J. Noelle, Bruce R. Blazar

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    B7 Expression on T Cells Down-Regulates Immune Responses through CTLA-4 Ligation via R-T Interactions

    B7 Expression on T Cells Down-Regulates Immune Responses through CTLA-4 Ligation via R-T Interactions mā Patricia A. Taylor, Christopher J. Lees, Sylvie Fournier, James P. Allison, Arlene H. Sharpe, Bruce R. Blazar

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions

    Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions mā Patricia A. Taylor, Christopher J. Lees, Jessica Wilson, Michael Ehrhardt, Matthew T. Campbell, Randolph J. Noelle, Bruce R. Blazar

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)

    Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD) mā Patricia A. Taylor, Michael Ehrhardt, Christopher J. Lees, Jakub Tolar, Brenda J. Weigel, Angela Panoskaltsis‐Mortari, Jonathan S. Serody, Volker Brinkmann, Bruce R. Blazar

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-L-Iduronidase in Mice With Mucopolysaccharidosis Type I

    Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-L-Iduronidase in Mice With Mucopolysaccharidosis Type I mā Mark J. Osborn, Ron McElmurry, Christopher J. Lees, Anthony P. DeFeo, Zhi-Ying Chen, Mark A. Kay, Luigi Naldini, Gordon J. Freeman, Jakub Tolar, Bruce R. Blazar

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

    TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection mā Patricia A. Taylor, Michael Ehrhardt, Christopher J. Lees, Angela Panoskaltsis‐Mortari, Arthur Μ. Krieg, Arlene H. Sharpe, William J. Murphy, Jonathan S. Serody, Hiroaki Hemmi, Shizuo Akira, Robert B. Levy, Bruce R. Blazar

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Rapid generation of Col7a1−/− mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells

    Rapid generation of Col7a1−/− mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells mā Beau R. Webber, Kyle T O'Connor, Ron McElmurry, Elise N Durgin, Cindy Eide, Christopher J. Lees, Megan Riddle, Wendy Mathews, Natasha Y. Frank, Mark A. Kluth, Christoph Ganss, Branden S. Moriarity, Markus H. Frank, Mark J. Osborn, Jakub Tolar

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa

    CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa mā Beau R. Webber, Mark J. Osborn, Amber McElroy, Kirk Twaroski, Cara-Lin Lonetree, Anthony P. DeFeo, Lily Xia, Cindy Eide, Christopher J. Lees, Ron McElmurry, Megan Riddle, Chong Jai Kim, Dharmeshkumar Patel, Bruce R. Blazar, Jakub Tolar

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Sleeping Beauty Transposon‐mediated Engineering of Human Primary T Cells for Therapy of CD19+ Lymphoid Malignancies

    Sleeping Beauty Transposon‐mediated Engineering of Human Primary T Cells for Therapy of CD19+ Lymphoid Malignancies mā Xin Huang, Hongfeng Guo, Johnthomas Kang, Suet Choi, Tom C. Zhou, Syam Tammana, Christopher J. Lees, Zhong-ze Li, Michael C. Milone, Bruce L. Levine, Jakub Tolar, Carl H. June, R. Scott McIvor, John E. Wagner, Bruce R. Blazar, Xianzheng Zhou

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: